Debenzergoline, or propyldebenzergoline, is a dopamine receptor agonist and partial ergoline. It is an analogue of ergoline in which the A ring of the ergoline ring system has been removed. The drug strongly inhibits prolactin secretion and produces antiparkinsonian effects in rodents. Debenzergoline was first described in the scientific literature by 1980.